Department of Microbiology and Immunology,1 Division of Infectious Diseases, University of Maryland School of Medicine,2 Department of Veterans Affairs, Baltimore, Maryland3
Received 10 June 2004/ Returned for modification 12 July 2004/ Accepted 11 August 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Like that for many other virulence factors (1), the expression of MR/P fimbriae undergoes phase variation (4). The mrp operon carries all of the genes that are necessary for the expression of MR/P fimbriae on the bacterial surface (mrpA, B, C, D, E, F, G, and H), as well as mrpJ, a repressor of flagellin synthesis. A 252-bp invertible element containing a canonical
70 promoter lies in the intergenic region between mrpA and mrpI; the latter gene encodes a recombinase and is divergently transcribed from the mrp operon (34). This invertible element is flanked by identical 21-bp inverted repeats upon which MrpI acts. MrpI flips the promoter region between the "on" direction, in which the promoter is able to drive expression of the mrp operon, and the "off" direction, in which the promoter is in the opposite orientation and is unable to drive expression. This recombinase-controlled form of phase variation is also observed for type 1 fimbriae of Escherichia coli, which are another important urinary tract virulence factor (1).
For this study, we investigated the role of MR/P fimbriae in biofilm production and colonization during ascending UTI. We discovered that MR/P fimbriae promote initial biofilm formation, with the fimbriae leading to aggregation of the bacteria. We determined that the majority of wild-type P. mirabilis cells produce MR/P fimbriae during ascending UTI. We also observed differential bladder colonization patterns for wild-type P. mirabilis and phase-locked mutants, with the lack of MR/P fimbriae leading to colonization of the lamina propria rather than the uroepithelium. Thus, the expression of MR/P fimbriae leads to bacterial aggregation and umbrella cell colonization while the prevention of MR/P fimbrial expression likely allows secondary adhesins to be expressed, which permit P. mirabilis to adhere to alternative regions of the bladder.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and media. The bacterial strains used for this study are listed in Table 1. Luria broth (LB) (10 g of peptone, 5 g of yeast extract, and 10 g of NaCl per liter) and LB agar (LB containing 1.5% [wt/vol] agar) were used as culture media. Nonswarming agar (10 g of peptone, 5 g of yeast extract, 0.5 g of NaCl, 5 ml of glycerol, and 20 g of agar per liter) was used on occasion (5). When necessary, media were supplemented with ampicillin (100 µg/ml). The MR/P phase-locked mutants were created by insertional inactivation with a kanamycin resistance gene of the gene encoding MrpI, the sole mrp operon recombinase, as previously described (15). Inactivation of the recombinase prevents the inversion of the invertible element preceding mrpA; the result is a mutant that either constitutively synthesizes MR/P fimbriae (MR/P ON) or produces no MR/P fimbriae (MR/P OFF).
|
, E. coli DH5
(pmrpA-J), and E. coli DH5
(pBluescript) were picked from isolated colonies, inoculated into LB supplemented with antibiotics when necessary for plasmid retention, and cultured with aeration at 37°C overnight. Cultures either were standardized to an optical density at 600 nm (OD600) of 0.5 (
108 CFU/ml) and used or were spread onto LB agar plates for overnight incubation at 37°C for future inoculation into mice. Mutant strains constitutively expressing GFP. Electroporation-competent P. mirabilis MR/P ON and MR/P OFF were transformed with BAC001 encoding green fluorescent protein (GFP) according to standard electroporation protocols (31).
Murine model of ascending UTI. Female (20 to 22 g, 6 to 8 weeks old) CBA mice (Jackson Laboratory, Bar Harbor, Maine) were inoculated transurethrally as previously described (8) with bacteria grown overnight on LB agar. These colonies were washed from the plate with phosphate-buffered saline (PBS) (0.138 M NaCl, 0.0027 M KCl, pH 7.4) and standardized to 109 CFU (for those producing GFP) or 108 CFU suspended in 0.05 ml of PBS. At the postinoculation times noted for each experiment, the bladders, ureters, and kidneys of the mice were aseptically removed. Bladders and kidneys were weighed and then sliced in half longitudinally. For determinations of the numbers of viable bacteria per gram of tissue, half of each bladder and kidney was homogenized by use of a mortar and pestle and then plated onto LB agar containing ampicillin (100 µg/ml). The plates were incubated overnight at 37°C. Organs containing >105 CFU/g of tissue were used for microscopy and immunohistochemistry.
Tissue preparation for confocal scanning laser microscopy. Bladders, ureters, and kidneys were fixed in 4% (vol/vol) paraformaldehyde containing 20% (wt/vol) sucrose at 4°C for 24 h. The tissues were embedded in Tissue-Tek OCT compound (Miles, Elkhart, Ind.), frozen in dry ice-ethanol, and held at 80°C until use. Ten-, 15- and 30-µm-thick sections were cut with a cryostat and stored at 20°C until they were used for staining. The tissues were permeabilized by a 30-min room-temperature incubation in 0.1% Triton X. After three 6-min washes in PBS, the tissue sections were incubated with appropriate antibodies.
Staining for MR/P fimbriae. A rabbit anti-MR/P serum was generated previously in our laboratory, and aliquots of the serum were stored at 20°C (15). Bladder, ureter, and kidney tissues were permeabilized as described above, incubated for 60 min at 37°C with rabbit anti-MrpA (1:200), and washed in PBS three times for 6 min each. The sections were then incubated with a secondary anti-rabbit antibody conjugated to Alexa Fluor 350 (Molecular Probes, Eugene, Oreg.) or Alexa Fluor 568 (1:1,000); this incubation was followed by three washes in PBS as described above. The sections were mounted with Vectashield fluorescent mounting medium (Vector Laboratories, Burlingame, Calif.), Vectashield with DAPI (4',6'-diamidino-2-phenylindole), or Vectashield with propidium iodide. Negative controls for MR/P binding specificity used the Alexa Fluor 350-conjugated anti-rabbit antibody without the initial step of applying the MR/P antibody.
Staining for ATF. An antiserum against ambient-temperature fimbriae (ATF) was generated previously in our laboratory (20), and aliquots of the serum were stored at 20°C. Vials of serum were thawed on ice and centrifuged for 1 min, and the supernatants were removed and placed in other tubes for further use. Dilutions of serum (1:100, 1:500, and 1:1,000) were added to permeabilized bladder sections of mice infected with either the ON GFP or OFF GFP strain. Sections were incubated overnight at 4°C, washed three times with PBS, and incubated for 1 h at 37°C with a 1:1,000 dilution of a secondary anti-rabbit antibody conjugated to Alexa Fluor 350 (Molecular Probes). After three more 6-min washes in PBS, the sections were dried and mounted with Vectashield mounting medium.
Confocal scanning laser microscopy. Slides were examined with a Zeiss LSM410 confocal laser scanning microscope with a 63x, NA 1.4 objective. The GFP and Alexa Fluor 568 signals, Cy3, and propidium iodide were excited with the 488- and 568-nm lines of a 50-mW KrAr laser and detected through 515- to 540-nm band-pass and 590-nm long-pass filters, respectively. A Coherent Enterprise 100-mW argon laser with laser lines of 351 and 364 nm excited the DAPI-stained nuclei and Alexa Fluor 350-conjugated MR/P fimbriae. Signals were detected through a 460-nm long-pass filter.
Assay for MR/P fimbria production during ascending UTI. The data used to determine the percentage of bacteria that expressed MR/P fimbriae were obtained by examinations of three fields of 63x sections each of bladders, ureters, and kidneys from three mice on days 2 and 4.
Tissue preparation for scanning electron microscopy. At 4 and 7 days postinoculation, the ureters of mice infected with wild-type P. mirabilis were ligated with surgical thread, the bladders were infused through the urethras with fixative (2% glutaraldehyde, 2% formaldehyde), and then the urethras were ligated. Full bladders were placed in vials of fixative and stored at 4°C for 2 to 4 days. The bladders were removed from the fixative, cut into quarters or eighths, rinsed with PBS three times for 5 min each, and then incubated with 0.1 M sodium cacodylate-3 mM calcium chloride two times for 5 min each. After the bladders were postfixed in 2% osmium tetroxide in 0.1 M sodium cacodylate for 1 h, they were rinsed in distilled water two times for 5 min each and then stained with 2% uranyl acetate for 30 min. The specimens were dehydrated by 5-min incubations in 50, 70, 90, and 100% ethanol. After two additional 5-min incubations in 100% ethanol, the specimens were critical point dried and sputter coated for 2 min with platinum-palladium.
Scanning electron microscopy. Murine bladders were examined in a Leo field emission scanning electron microscope (Carl Zeiss, Inc.) housed at the Johns Hopkins Microscopy Facility. The bladders were viewed by using a 1- to 2.5-kV operating voltage.
Bladder washout studies for mice experimentally infected with wild-type P. mirabilis HI4320 and phase-locked mutants.
Strains were tested in cochallenge experiments by transurethrally inoculating mice with
108 CFU of an equal mixture of wild-type P. mirabilis HI4320 and MR/P ON or wild-type P. mirabilis HI4320 and MR/P OFF. Independent infections with each strain were also examined. Eight female CBA mice were used for each cochallenge experiment. The bladders were washed with 0.05 ml of PBS at 24 h postinoculation and then homogenized. Both the wash fluid and the homogenized bladders were immediately plated (on LB agar [to obtain total CFU] and on LB agar supplemented with kanamycin [20 µg/ml] [to calculate the numbers of mutant bacteria]) to determine the numbers of nonadherent bacteria present in the wash fluid and the numbers of adherent bacteria present in the homogenized bladders. For independent challenges, mice were inoculated as described earlier with either P. mirabilis HI4320, MR/P ON, or MR/P OFF. After 24 h, the bladders were treated as described above, and both the wash fluid and the homogenized bladders were plated on LB agar (P. mirabilis HI4320) or LB agar supplemented with kanamycin (MR/P ON and MR/P OFF). Ten female CBA mice were used for each independent challenge experiment.
Measurement of swarm zone areas for wild-type P. mirabilis HI4320, MR/P ON, and MR/P OFF.
Samples (5 µl) of overnight cultures of wild-type P. mirabilis HI4320, MR/P ON, and MR/P OFF were spotted onto the middle of nine swarming plates. The abilities of the three P. mirabilis strains (wild type, MR/P ON, and MR/P OFF) to swarm were compared by determining the areas of the swarm zones after 12.5 h at 37°C. The areas were determined by using the formula for the area of an ellipse [area = (height x width x
)/4].
Crystal violet biofilm assay. The assay for biofilm formation used for this study was adapted from the method of O'Toole and Kolter (26) and is based on the ability of bacteria to form biofilms on solid surfaces such as polyvinyl chloride. Standardized cell cultures (20 µl) were added to 180 µl of fresh, filter-sterilized urine in non-tissue-culture-treated polyvinyl chloride U-bottomed 96-well plates (Falcon 3911; Becton Dickinson Labware, Franklin Lakes, N.J.). Wells filled with sterile urine only were included as negative controls. The plates were incubated for 24 h at 30°C. Planktonic bacteria and urine were decanted, and fresh, filter-sterilized urine was added. The plates were incubated for another 24 h at 30°C and then examined for biofilm formation via a crystal violet assay. The urine, as well as any nonadherent bacteria, was decanted from the wells, and any remaining planktonic cells were removed by three rinses with sterile distilled water (dH2O). The wells were air dried, and adherent bacteria were stained for 15 min with 0.1% crystal violet. After three rinses with sterile dH2O, bacterium-bound dye was released by the addition of 200 µl of dimethyl sulfoxide (Sigma-Aldrich Company). One hundred microliters of the dimethyl sulfoxide-crystal violet solution was transferred to Costar 96-well flat-bottomed polystyrene plates (Corning Incorporated, Corning, N.Y.), and the OD595 was determined on an ELX800 universal microplate reader (Bio-Tek Instruments, Inc., Winooski, Vt.).
SEM evaluation of biofilm formation on cover glass. A standardized culture (20 µl) was added to 180 µl of sterile, fresh, pooled human urine on a no. 1 18-mm-square cover glass (Corning Incorporated Life Sciences, Acton, Mass.). After 18 h, the urine and planktonic cells were decanted, and the cover glass was rinsed three times with sterile dH2O and processed for scanning electron microscopy (SEM) as described above.
Confocal laser scanning microscopic evaluation of biofilm formation on cover glass. A standardized culture (20 µl) was added to 180 µl of sterile, fresh, pooled human urine on an 18-mm-square cover glass (Corning Incorporated Life Sciences). Every 48 h, the urine and planktonic bacteria were decanted off the cover glass, and fresh sterile urine was added. After 7 days, the urine and planktonic cells were decanted, and the cover glass was rinsed three times with sterile dH2O and examined with a Zeiss LSM410 confocal laser scanning microscope with a 63x, NA 1.4 objective. GFP-expressing bacteria were excited with the 488-nm line of a 50-mW KrAr laser and detected through a 515- to 540-nm band-pass filter.
| RESULTS |
|---|
|
|
|---|
109 CFU) of the bacterial suspension as described in Materials and Methods. The bacteria in the inoculum did not produce MR/P fimbriae, as determined by anti-MrpA staining (Fig. 1A) and confocal microscopy. MRP ON(pBAC001) cells were plated and examined for MR/P fimbriation by the same methods as those used for the positive control. MRP ON (green) cells bound by anti-MrpA (red) stained yellow, indicating the colocalization of bacteria and fimbriae (Fig. 1B). At 2 and 4 days postinoculation, the bladders, ureters, and kidneys were removed from the mice, and the infecting bacteria were analyzed for MR/P fimbriation by use of the anti-MrpA antibody and laser scanning confocal microscopy. The antibody bound specifically to bacteria producing MR/P fimbriae (Fig. 1C). In animal experiments, bound anti-MrpA was incubated with Alexa Fluor 350, yielding green-staining GFP-producing bacteria that colocalized with the blue-staining MrpA protein. Fig. 1C shows two bacteria that did not produce MR/P fimbriae (green) and four others that did (green and blue). The majority of P. mirabilis cells (54 to 94%) infecting the urinary tract produced MR/P fimbriae in all three urinary tract organs (Fig. 1D).
|
/4), were 17.26 ± 6.47 cm2, 18.18 ± 5.5 cm2, and 28.5 ± 6.7 cm2 for the wild type, MR/P ON, and MR/P OFF, respectively (Fig. 2D), after 12.5 h. The difference in swarm zone areas was statistically significant when MR/P OFF was compared to either P. mirabilis HI4320 (P = 0.0025) or MR/P ON (P = 0.0028) by Student's two-tailed t test with Welch's correction. Therefore, the prevention of mrp operon transcription allowed faster swarming. However, constitutive expression of the mrp operon, including mrpJ, which encodes a repressor of flagellin synthesis, did not significantly slow the swarming behavior of the MR/P ON strain compared to the wild-type strain (P > 0.05).
|
transformed with genes encoding MR/P fimbriae formed pellicles at the air-broth interface when grown statically overnight at 37°C. When cultures were incubated with shaking, aggregates formed on the surface. Since many fimbriae are recognized as being important for biofilm formation (6, 7, 26, 29, 32), we performed a crystal violet biofilm assay (26) with P. mirabilis HI4320, MR/P ON, and MR/P OFF to determine the contribution of MR/P fimbriae to biofilm formation. After 2 days of incubation in sterile urine at 30°C, with fresh urine added at 24 h, MR/P ON formed a significantly larger biofilm than either MR/P OFF or the wild-type strain (P = 0.03 and 0.05, respectively) (Fig. 3). However, the expression of MR/P fimbriae from a plasmid in E. coli DH5
, a laboratory strain of E. coli, was not sufficient to initiate biofilm formation, as the average biofilm formed by E. coli DH5
expressing MR/P fimbriae was not statistically different from that formed by a vector control (P = 0.4).
|
|
10 µm thick while wild-type P. mirabilis formed a biofilm with a maximum thickness of 63 µm (Fig. 5A). Therefore, the constitutive production of MR/P fimbriae or the lack of MR/P fimbria expression prevents maximal biofilm development.
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Previous reports from our laboratory and others indicated that MR/P fimbriae are an important P. mirabilis virulence factor in ascending UTI. One week after transurethral inoculation in the mouse, an mrpA mutant (mrpA encodes the major fimbrial subunit) was outcompeted by the wild-type strain in cochallenge experiments (15). For independent challenges, two outcomes were noted. First, the mrpA mutant was recovered in significantly lower numbers than the parent strain from the urine, bladders, and kidneys in a CBA mouse model of ascending UTI. Overall, colonization was reduced 6-, 28-, and 18-fold, respectively (3). In a second study, a strain that was incapable of making MR/P fimbriae was able to colonize the bladder in significant numbers (15). Our present study supports the latter, more recent experiment. Thus, MR/P fimbriae contribute to but are not absolutely required for colonization of the murine urinary tract. Therefore, colonization likely involves several factors, one of which is MR/P fimbriae.
Use of MR/P phase-locked mutants. To investigate the possible roles of MR/P fimbriae, we used mutants (15) that either constitutively expressed or lacked MR/P fimbriae. In these mutants, mrpI was insertionally inactivated with a kanamycin cassette via homologous recombination. MrpI is the sole recombinase that is capable of switching the invertible element governing MR/P expression, and thus this insertion created two phase-locked mutants. The first mutant always expressed MR/P fimbriae (MR/P ON), while the other mutant never expressed MR/P fimbriae (MR/P OFF). We tested the ability of the mutants to produce MR/P fimbriae by using several methods. First, a PCR-based assay to determine the orientation of the invertible element showed that the promoter always remained in the expected orientation, the orientation to drive expression of the mrp operon in the MR/P ON strain or the opposite orientation in the MR/P OFF strain (15). The orientation of the invertible element never varied, whether bacteria were cultured on agar or in LB or were inoculated into mice and then plated from bladder and kidney homogenates. Secondly, the ability to agglutinate chicken erythrocytes in the presence of mannose, a phenotype consistent with MR/P fimbria production, was always present in the MR/P ON strain and never occurred in the MR/P OFF strain (15). Thirdly, in this study, antibodies generated against MrpA (the major pilin subunit) bound MR/P ON and did not bind MR/P OFF, regardless of whether the organisms were cultured in LB or on agar or were assayed from sections of infected mouse bladders, ureters, or kidneys.
Swarming motility. To characterize these mutants, we measured their ability to swarm, a phenotype that is associated with P. mirabilis flagella and inversely associated with MR/P fimbria production (9). On agar, MR/P ON bacteria, which constitutively expressed MR/P fimbriae, were able to swarm as quickly as cells of the parental wild-type strain, which did not produce MR/P fimbriae when cultured on agar. This was an unexpected result because the MR/P ON strain must use energy and resources to synthesize fimbriae, a phenotype that is thought to be unnecessary for growth on agar, yet fimbrial synthesis did not inhibit the swarming motility. MR/P ON bacteria produced both fimbriae and flagella, a phenotype that is not seen with wild-type P. mirabilis. This concurrent production of organelles with functions that are thought to be contradictory provides an interesting insight regarding the regulation of synthesis of these organelles. First, this confirms the published report by Li and colleagues (15) that MrpI is the sole recombinase that is capable of flipping the mrp operon promoter. Since the bacteria continued to express fimbriae in an environment where they are not usually expressed, such as when P. mirabilis was cultured on agar or during swarming, there appears to be no other recombinase that is capable of switching the invertible element.
Secondly, the constitutive expression of mrpJ, which is the last gene in the mrp operon and encodes a repressor of flagellin synthesis (17), did not hinder flagellin production during swarming in this strain. Li and colleagues showed that the constitutive expression of mrpJ from a high-copy-number plasmid reduced swarming (17). However, MR/P ON expresses mrpJ from a single chromosomal copy of the gene. Therefore, this gene is not expected to be highly expressed, and certainly not as highly as from a high-copy-number plasmid. Although the environmental cues for swarming led to an approximately eightfold increase in the expression of flaA (the flagellin gene) (5), this level was not high enough to account for the thousands of flagella on the surfaces of swarmer cells. Perhaps there is some posttranscriptional regulation that aids in the increased numbers of flagella produced on the surfaces of swarmer cells. Since MrpJ is a putative DNA binding protein and hence works at the transcriptional level, its presence would not affect posttranscriptional modifications made during swarming.
The observation that MR/P OFF swarmed significantly faster than the wild type was also unexpected. The numbers of flagella on swarming wild-type bacteria and swarming MR/P OFF bacteria appeared to be similar when viewed by SEM, and thus the reason for the increased velocity of MR/P OFF is not yet understood. On agar, wild-type bacteria do not express MR/P fimbriae, and the MR/P OFF mutant does not express fimbriae either. Therefore, one would hypothesize that the two strains would swarm at similar velocities. This was, however, not the case. The loss of MrpI also does not explain the increased swarming speed of MR/P OFF, because MrpI is not functional in MR/P ON, which swarmed at the same velocity as the wild type. Although it has been documented that wild-type P. mirabilis HI4320 does not produce MR/P fimbriae when cultured on agar, there may be low levels of transcription of the mrp operon, including mrpJ, and thus there may be low levels of MrpJ in the bacteria in the absence of fimbrial production. If this occurs in the wild-type strain, then it almost certainly happens in the MR/P ON strain, wherein the genes of the mrp operon are transcribed and translated. The mechanism by which MrpJ affects motility is unknown. High-level expression of mrpJ from a plasmid represses swarming, and thus there appears to be a role for MrpJ during swarming (17). Currently, however, the ability of the MR/P OFF mutant to swarm at an increased velocity remains unexplained.
Biofilm formation. Although earlier studies investigated the initial stages of UTI in a mouse model, biofilm formation has been shown to be important for persistent infections, particularly for catheter-associated bacteriuria. Thus, we investigated the contribution of MR/P fimbriae to biofilm formation. Biofilm formation of P. mirabilis on catheter material is a well-documented phenomenon (19, 21, 23, 30). However, it is unknown which gene products are important for P. mirabilis biofilm development. Pratt and Kolter suggested that gene products which are important for biofilm development are also important for pathogenesis (29). Autoaggregation likely aids bacteria in persisting in the host despite actions of the immune system. Bacteria that are adherent to the epithelium and encased by other bacteria may be protected from neutrophils and the activity of complement. Perhaps the autoaggregation of bacteria allows an increased density of bacteria that permits signaling molecules to be passed among the population. This could enable bacteria to determine when they have reached a critical mass, triggering virulence gene expression, such as occurs as the result of quorum sensing in Pseudomonas aeruginosa (12, 27). The ability to autoaggregate is also associated with the ability of Lactobacillus spp. to adhere to the host epithelium (10). Finally, aggregation might permit quantitatively more adherence, with bacteria piling on top of each other. Therefore, we tested the contribution of MR/P fimbriae to biofilm formation and, perhaps, pathogenesis.
The constitutive expression of MR/P fimbriae enhanced biofilm development in a 48-h crystal violet biofilm assay. However, MR/P OFF, which does not express MR/P fimbriae, was able to form a biofilm similar to that formed by wild-type P. mirabilis HI4320. E. coli DH5
expressing MR/P fimbriae constitutively from a plasmid was unable to form biofilms. Therefore, MR/P fimbriae are neither necessary nor sufficient to initiate biofilm formation, yet if they are constitutively expressed, these surface structures enhance biofilm formation.
To examine the structures of the biofilms, we grew wild-type P. mirabilis and the two mutants on cover glass in sterile urine for 18 h at 30°C. The biofilms were rinsed with sterile distilled water and processed for SEM. We then examined the biofilms by SEM. MR/P ON formed a characteristic three-dimensional biofilm structure with channels and mounds, while MR/P OFF and wild-type P. mirabilis were both in the initial stage of adherence and did not form microcolonies. Therefore, the loss of the ability to express MR/P fimbriae did not abolish the ability of the bacteria to form biofilms, as the wild-type and MR/P OFF biofilms were similar. The constitutive expression of MR/P fimbriae, however, leads to quicker biofilm formation. MR/P ON did not merely form microcolonies of aggregated bacteria. The biofilms formed by MR/P ON were consistent with the definition of a biofilm, with mushroom-shaped mounds with channels flowing between them. Perhaps the autoaggregative character of MR/P ON allowed the initial adherence to the coverslip and to each other to occur rapidly, thus allowing the bacteria to quickly move to the next stage of biofilm development, while the wild-type strain and MR/P OFF took more time to undergo these initial steps. Therefore, the constitutive production of MR/P fimbriae enhances biofilm development during the first 48 h.
However, after 7 days of biofilm formation by GFP-expressing bacteria, the wild-type strain created a thick (maximum depth,
63 µm) biofilm while both mutants were able to form a biofilm with only one-fifth the thickness of the wild-type biofilm (maximum depth,
12 µm). We were able to measure the biofilm thicknesses by taking z sections of the biofilms by confocal scanning laser microscopy. Studies conducted in our laboratory showed that the production of GFP did not affect P. mirabilis growth or biofilm development (data not shown). Therefore, while the constitutive production of MR/P fimbriae on bacterial surfaces enhances biofilm development in the early stages, the ability to switch off the expression of these surface organelles is important for the biofilm to develop fully. Pratt and Kolter (29) studied the development of biofilms and found that many insertional mutations in genes encoding diverse products, such as flagella and type 1 fimbriae, inhibited maximum E. coli biofilm production.
Bladder washout studies. The ability of MR/P OFF to persist in the bladder despite vigorous washing was a surprising result. Typically, fimbriae produced via the chaperone or usher pathway are adhesive organelles. Therefore, we would have predicted that the lack of this adhesin in MR/P OFF would allow the bacteria to be washed from the bladder more easily than bacteria producing MR/P fimbriae. This was not the case, however, as the proportions of bacteria washed from bladders during our assay were similar for wild-type P. mirabilis, MR/P ON, and MR/P OFF. Two possible explanations for this observation can be offered. First, the washing may have been too vigorous. PBS was delivered into the bladder, withdrawn, and reinjected 10 times. We washed the bladders vigorously because we wanted more turbulence than that provided by the flushing mechanism of micturation. Perhaps if we had adopted a less strenuous protocol, more subtle differences among the strains would have been seen. A second possible explanation is that MR/P OFF cells express surface adhesins that are not normally thought to be important for P. mirabilis during bladder colonization and that these adhesins compensate for the lack of MR/P fimbriae. One of these possible atypically expressed adhesins is ATF. ATF is a fimbrial type that is typically expressed in P. mirabilis at 23°C (20). Zunino and colleagues tested the ability of an ATF null mutant to colonize the urinary tract and found that it colonized as well as the wild type (35). We have shown, by using a rabbit anti-ATF antiserum, that MR/P OFF expresses ATF in bladder tissue. This does not prove, however, that this fimbrial type is the cause of the bladder washout results or results discussed later regarding the colonization patterns of the strains. It is merely an observation that when one fimbrial system is disabled, other adhesins that may not have been expressed previously or that were not necessarily important in healthy wild-type bacteria in this environment are produced.
Colonization of the bladder. We observed distinct patterns of colonization of P. mirabilis in the presence and absence of MR/P fimbrial expression. We used SEM to qualitatively examine the colonization patterns of P. mirabilis HI4320, MR/P ON, and MR/P OFF in the bladder. MR/P OFF localized exclusively to areas of bladder cell exfoliation where the connective tissue and lamina propria were exposed. Indeed, without MR/P fimbriae, P. mirabilis cells were apparently not able to colonize the luminal surfaces of undamaged epithelium, but instead were found as single bacteria attached to the areas of exfoliation. Bacteria adhered to areas of trauma in which the umbrella cells had exfoliated, leaving the underlying basement membrane exposed. This is consistent with examples in the literature of bacteria binding to areas that are not typically exposed in the lumen of an organ. For example, Kukkonen and colleagues showed type 1 fimbria-mediated adherence to the laminin network in basement membranes in Salmonella enterica and E. coli (11).
In contrast to MR/P OFF, MR/P ON heavily colonized the umbrella (uroepithelial) cells of the bladder. At a high magnification (x250,000), MR/P ON bacteria appeared to interact via fimbria-like appendages. Since these bacteria overproduce MR/P fimbriae and since a rabbit anti-MrpA serum bound MR/P ON cells isolated from Luria-Bertani broth, LB agar, and bladder, ureter, and kidney tissues, these surface appendages were most likely MR/P fimbriae. The evidence gathered in this study of the autoaggregative properties of MR/P fimbriae is not as surprising as the previous results. The autoaggregative properties of MR/P fimbriae were described previously, when the mrp operon was constitutively expressed from a plasmid in E. coli DH5
. The bacteria formed a pellicle at the liquid-air interface of the test tube when grown in LB (15). When MR/P ON was pelleted, it formed tight clumps and was difficult to resuspend (X. Li, personal observation). Here we documented fimbria-fimbria interactions of bacteria constitutively expressing MR/P fimbriae in the urinary tract.
P. mirabilis HI4320 formed colonies on umbrella cells, which was reminiscent of both mutants' colonization patterns. Some wild-type bacteria were found in autoaggregated patterns. An examination of these bacteria at a higher magnification revealed a fuzzy appearance similar to that of MR/P ON cells. Occasionally, P. mirabilis HI4320 colonized areas of exfoliation. These colonies contained bacteria that lay as single cells upon the epithelium. These bacteria had smoother surfaces that were more reminiscent of MR/P OFF cells. This behavior was consistent with the observation that the majority of P. mirabilis bacteria produced MR/P fimbriae in the bladder, so at a population level, the bacteria will either aggregate or bind host tissues singly. There has been much more information published on the colonization patterns of uropathogenic E. coli than on those of P. mirabilis. For example, Hultgren and colleagues have published observations of E. coli invading the bladder uroepithelium and forming foci of intracellular bacteria. They also observed these bacteria reemerging in a filamentous form 6 h later (24). In a recent Science article, they published observations of intracellular E. coli forming biofilms (2). These bacteria produced surface proteins, such as type 1 fimbriae and Ag43, that have been shown to be expressed during biofilm formation. We saw no evidence of P. mirabilis behaving in this manner. In MR/P OFF, perhaps the inability to express MR/P fimbriae allows the expression of alternate adhesins with affinities for receptors on the basal membrane underlying the umbrella cells. Cross-regulation by fimbriae as well as by flagella has been well documented (3, 15, 25, 34). As described earlier, MR/P OFF cells express ATF in vivo, a phenotype which is thought not to occur during wild-type colonization of the urinary tract. The inability to express MR/P fimbriae abolishes binding to the normal bladder epithelium and the ability to autoaggregate, but it appears to allow bacteria to express alternate adhesive organelles, such as laminin, fibronectin, or collagens, so that the bacteria can bind alternative sites in the bladder during ascending UTI. Type 1 fimbriated S. enterica and E. coli have been shown to bind laminin (11); therefore, not only are bacteria able to bind to the luminal side of epithelial cells, but they are also capable of taking advantage of a disrupted epithelium.
In this study, we have shown that MR/P fimbriae, a well-established virulence factor, enhance the autoaggregation of P. mirabilis during ascending UTI. In addition, the majority of infecting bacteria in the bladder, ureters, and kidneys produce these autoaggregative MR/P fimbriae.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Abraham, J. M., C. S. Freitag, J. R. Clements, and B. I. Eisenstein. 1985. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc. Natl. Acad. Sci. USA 82:5724-5727. |
| 2. | Anderson, G. G., J. J. Palermo, J. D. Schilling, R. Roth, J. Heuser, and S. J. Hultgren. 2003. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105-107. |
| 3. | Bahrani, F. K., G. Massad, C. V. Lockatell, D. E. Johnson, R. G. Russell, J. W. Warren, and H. L. Mobley. 1994. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect. Immun. 62:3363-3371. |
| 4. | Bahrani, F. K., and H. L. Mobley. 1993. Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene. J. Bacteriol. 175:457-464. |
| 5. | Belas, R. 1994. Expression of multiple flagellin-encoding genes of Proteus mirabilis. J. Bacteriol. 176:7169-7181. |
| 6. | Danese, P. N., L. A. Pratt, S. L. Dove, and R. Kolter. 2000. The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol. Microbiol. 37:424-432.[CrossRef][Medline] |
| 7. | D'Argenio, D. A., M. W. Calfee, P. B. Rainey, and E. C. Pesci. 2002. Autolysis and autoaggregation in Pseudomonas aeruginosa colony morphology mutants. J. Bacteriol. 184:6481-6489. |
| 8. | Hagberg, L., I. Engberg, R. Freter, J. Lam, S. Olling, and C. Svanborg Eden. 1983. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect. Immun. 40:273-283. |
| 9. | Jansen, A. M., C. V. Lockatell, D. E. Johnson, and H. L. T. Mobley. 2003. Visualization of Proteus mirabilis morphotypes in the urinary tract: the elongated swarmer cell is rarely observed in ascending urinary tract infection. Infect. Immun. 71:3607-3613. |
| 10. | Kos, B., J. Suskovic, S. Vukovic, M. Simpraga, J. Frece, and S. Matosic. 2003. Adhesion and aggregation ability of probiotic strain Lactobacillus acidophilus M92. J. Appl. Microbiol. 94:981-987.[CrossRef][Medline] |
| 11. | Kukkonen, M., T. Raunio, R. Virkola, K. Lahteenmaki, P. H. Makela, P. Klemm, S. Clegg, and T. K. Korhonen. 1993. Basement membrane carbohydrate as a target for bacterial adhesion: binding of type I fimbriae of Salmonella enterica and Escherichia coli to laminin. Mol. Microbiol. 7:229-237.[CrossRef][Medline] |
| 12. | Latifi, A., M. K. Winson, M. Foglino, B. W. Bycroft, G. S. Stewart, A. Lazdunski, and P. Williams. 1995. Multiple homologues of LuxR and LuxI control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1. Mol. Microbiol. 17:333-343.[CrossRef][Medline] |
| 13. | Li, X., C. V. Lockatell, D. E. Johnson, M. C. Lane, J. W. Warren, and H. L. T. Mobley. 2004. Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Infect. Immun. 72:66-75. |
| 14. | Li, X., D. E. Johnson, and H. L. Mobley. 1999. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis. Infect. Immun. 67:2822-2833. |
| 15. | Li, X., C. V. Lockatell, D. E. Johnson, and H. L. Mobley. 2002. Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol. Microbiol. 45:865-874.[CrossRef][Medline] |
| 16. | Li, X., and H. L. Mobley. 2002. Vaccines for Proteus mirabilis in urinary tract infection. Int. J. Antimicrob. Agents 19:461-465.[CrossRef][Medline] |
| 17. | Li, X., D. A. Rasko, C. V. Lockatell, D. E. Johnson, and H. L. Mobley. 2001. Repression of bacterial motility by a novel fimbrial gene product. EMBO J. 20:4854-4862.[CrossRef][Medline] |
| 18. | Li, X., H. Zhao, L. Geymonat, F. Bahrani, D. E. Johnson, and H. L. Mobley. 1997. Proteus mirabilis mannose-resistant, Proteus-like fimbriae: MrpG is located at the fimbrial tip and is required for fimbrial assembly. Infect. Immun. 65:1327-1334.[Abstract] |
| 19. | Liaw, S. J., H. C. Lai, S. W. Ho, K. T. Luh, and W. B. Wang. 2003. Role of RsmA in the regulation of swarming motility and virulence factor expression in Proteus mirabilis. J. Med. Microbiol. 52:19-28. |
| 20. | Massad, G., F. K. Bahrani, and H. L. Mobley. 1994. Proteus mirabilis fimbriae: identification, isolation, and characterization of a new ambient-temperature fimbria. Infect. Immun. 62:1989-1994. |
| 21. | McLean, R. J., J. R. Lawrence, D. R. Korber, and D. E. Caldwell. 1991. Proteus mirabilis biofilm protection against struvite crystal dissolution and its implications in struvite urolithiasis. J. Urol. 146:1138-1142.[Medline] |
| 22. | Mobley, H. L., and J. Warren. 1987. Urease-positive bacteriuria and obstruction of long-term urinary catheters. J. Clin. Microbiol. 25:2216-2217. |
| 23. | Morris, N. S., D. J. Stickler, and C. Winters. 1997. Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? Br. J. Urol. 80:58-63.[Medline] |
| 24. | Mulvey, M. A., J. D. Schilling, and S. J. Hultgren. 2001. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 69:4572-4579. |
| 25. | O'Toole, G. A., and R. Kolter. 1998. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30:295-304.[CrossRef][Medline] |
| 26. | O'Toole, G. A., and R. Kolter. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449-461.[CrossRef][Medline] |
| 27. | Pearson, J. P., E. C. Pesci, and B. H. Iglewski. 1997. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J. Bacteriol. 179:5756-5767. |
| 28. | Pellegrino, R., U. Galvalisi, P. Scavone, V. Sosa, and P. Zunino. 2003. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections. FEMS Immunol. Med. Microbiol. 36:103-110.[CrossRef][Medline] |
| 29. | Pratt, L. A., and R. Kolter. 1998. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol. Microbiol. 30:285-293.[CrossRef][Medline] |
| 30. | Sabbuba, N., G. Hughes, and D. J. Stickler. 2002. The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters. BJU Int. 89:55-60.[Medline] |
| 31. | Sambrook J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 32. | Schembri, M. A., K. Kjaergaard, and P. Klemm. 2003. Global gene expression in Escherichia coli biofilms. Mol. Microbiol. 48:253-267.[CrossRef][Medline] |
| 33. | Warren, J. W., J. H. Tenney, J. M. Hoopes, H. L. Muncie, and W. C. Anthony. 1982. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J. Infect. Dis. 146:719-723.[Medline] |
| 34. | Zhao, H., X. Li, D. E. Johnson, I. Blomfield, and H. L. Mobley. 1997. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Mol. Microbiol. 23:1009-1019.[CrossRef][Medline] |
| 35. | Zunino, P., L. Geymonat, A. G. Allen, C. Legnani-Fajardo, and D. J. Maskell. 2000. Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection. FEMS Immunol. Med. Microbiol. 29:137-143.[CrossRef][Medline] |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||